Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00974792. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Oxaliplatin and Prednisolone (Ox-P) for Patients With Relapsed or Refractory Marginal Zone B-cell Lymphoma(MZL)
ClinicalTrials.gov study NCT01068392. IPD Sharing: Not stated. Countries: 1. Publications: 1.
SAR3419 as Single Agent in Relapsed-Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients
ClinicalTrials.gov study NCT01472887. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT02767674. IPD Sharing: YES. Countries: 1. Publications: 6.
Phenotypic and Functional Characterisation of Human B-cell Response in Pemphigus
ClinicalTrials.gov study NCT04117529. IPD Sharing: NO. Countries: 1. Publications: 5.
Study of Vorinostat (MK-0683) With Follicular Lymphoma (FL), Other Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL), or Mantle Cell Lymphoma (MCL) Participants (MK-0683-103)
ClinicalTrials.gov study NCT00875056. IPD Sharing: YES. Countries: 0. Publications: 1.
A Phase I Study of Bendamustine Hydrochloride in Patients With Indolent B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00389051. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Subcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT05660967. IPD Sharing: NO. Countries: 12. Publications: 0.
Abatacept to Silence Anti-citrullinated Protein Antibody-expressing B Cells in Rheumatoid Arthritis (ASCARA)
ClinicalTrials.gov study NCT03492658. IPD Sharing: YES. Countries: 1. Publications: 3.
Ibrutinib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT02219737. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Mini-Chop Plus Ofatumumab To Treat Cd 20+ Diffuse Large B-Cell Lymphoma In Patients Aged Over 80 Years
ClinicalTrials.gov study NCT01195714. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7443904 in Combination With Glofitamab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT05219513. IPD Sharing: NO. Countries: 6. Publications: 1.
A Study of Obinutuzumab in Combination With Chemotherapy in Participants With CD20+ B-Cell Follicular Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00825149. IPD Sharing: Not stated. Countries: 6. Publications: 4.
A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory T or B Cell Malignancies (COBALT-LYM)
ClinicalTrials.gov study NCT04502446. IPD Sharing: NO. Countries: 3. Publications: 2.
Pilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell Malignancies
ClinicalTrials.gov study NCT02315118. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dose Dense Chemotherapy and Rituximab for Young High Risk Diffuse Large B-Cell Lymphoma Patients (CRY-04)
ClinicalTrials.gov study NCT01502982. IPD Sharing: Not stated. Countries: 4. Publications: 4.
Study of Radiolabeled Monoclonal Antibody Anti-B1 for the Treatment of B-Cell Lymphomas and Extended Study to Determine the Safety and Efficacy of Coulter Clone® 131Iodine-B1 Radioimmunotherapy of Adv
ClinicalTrials.gov study NCT01536561. IPD Sharing: YES. Countries: 0. Publications: 1.
A Phase I Study of YY-20394 in Patients With B Cell Hematologic Malignancies
ClinicalTrials.gov study NCT03757000. IPD Sharing: UNDECIDED. Countries: 1. Publications: 9.
B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome
ClinicalTrials.gov study NCT01156909. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations
ClinicalTrials.gov study NCT03793140. IPD Sharing: YES. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.